18:00 EST Rain Therapeutics trading halted, news pending
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on RAIN:
- Rain Oncology reports Q3 EPS (19c), consensus (27c)
- Rain Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
- Rain Oncology Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
- Rain Oncology confirms receipt of unsolicited proposal from Concentra
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue